Energenesis Biomedical CO.,Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 2.479 million compared to TWD 2.424 million a year ago. Operating loss was TWD 65.454 million compared to TWD 45.907 million a year ago. Net loss was TWD 64.584 million compared to TWD 43.901 million a year ago. Basic loss per share was TWD 1.31 compared to TWD 1.08 a year ago.